Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States.
about
Underdiagnosis of Attention-Deficit/Hyperactivity Disorder in Adult PatientsUsing Sibling Designs to Understand Neurodevelopmental Disorders: From Genes and Environments to Prevention ProgrammingProfile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorderEffectiveness and cost-effectiveness of a brief school-based group programme for parents of children at risk of ADHD: a cluster randomised controlled trialBrief report: forecasting the economic burden of autism in 2015 and 2025 in the United StatesA Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate.Italian regional health service costs for diagnosis and 1-year treatment of ADHD in children and adolescents.Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case.Association Between Altitude and Regional Variation of ADHD in YouthAttention-deficit/hyperactivity disorder and impairment in executive functions: a barrier to weight loss in individuals with obesity?The association of attention deficit hyperactivity disorder with socioeconomic disadvantage: alternative explanations and evidenceImpact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial.Evaluating the construct validity of adult ADHD and SCT among college students: a multitrait-multimethod analysis of convergent and discriminant validity.Sociodemographics, Comorbidities, Healthcare Utilization and Work Productivity in Japanese Patients with Adult ADHD.Association between societal costs and treatment response in children and adolescents with ADHD and their parents. A cross-sectional study in the Netherlands.Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD.Student-Perceived School Climate Is Associated With ADHD Medication Treatment Among Adolescents in Medicaid.Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial.Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled TrialUse of Mental Health Services by Children Ages Six to 11 With Emotional or Behavioral DifficultiesAnnual research review: Child and adolescent mental health interventions: a review of progress in economic studies across different disorders.Preschool hyperactivity is associated with long-term economic burden: evidence from a longitudinal health economic analysis of costs incurred across childhood, adolescence and young adulthood.Prenatal exposure to polybrominated diphenyl ethers and child attention problems at 3-7 years.Apgar Scores Are Associated with Attention-Deficit/Hyperactivity Disorder Symptom Severity.Financial Dependence of Young Adults with Childhood ADHD.The multiple faces of interparental conflict: Implications for cascades of children's insecurity and externalizing problems.Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorderPractitioner Review: Pathways to care for ADHD - a systematic review of barriers and facilitatorsDiagnosis, treatment, and burden of illness among adults with attention-deficit/hyperactivity disorder in Europe.Real-World Dosing Patterns of Atomoxetine in Adults with Attention-Deficit/Hyperactivity DisorderAttention-Deficit/Hyperactivity Disorder (ADHD) and Obesity: Update 2016.Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.The costs and benefits of diagnosis of ADHD: commentary on Holden et alPrevalence of obesity in attention-deficit/hyperactivity disorder: study protocol for a systematic review and meta-analysis.Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes.Individual treatment response in attention-deficit/hyperactivity disorder: broadening perspectives and improving assessments.The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD.Developments and challenges in the diagnosis and treatment of ADHD.The relationship between ADHD and obesity: implications for therapy.Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents.
P2860
Q22241098-EAEF3D7C-ED4D-41D6-AAC2-5205816DFAB7Q26799923-0CD307F0-E7CA-4D53-85BC-EE6FFD4999AFQ27692647-2F45AF60-E853-490D-8CB4-A12858749FC2Q28321107-2499F24F-6D77-4306-B185-1E55A50A156FQ28950763-1D5D2C31-5366-484D-87FA-2C13FFFFEFD2Q30489718-3EB05CD7-4883-427E-9E5A-951C28AD3D05Q33617689-03808AD9-488B-4ABD-A7D6-5EB2760B9868Q33829034-1501BDA8-0A86-4372-9B3E-037558B4BD8BQ33905439-DB8609D3-D659-4717-95DC-EE9B962C109CQ34481709-57947BBC-627B-4398-83A5-CB2040EB3A90Q34678435-0453AB9F-CFBD-46E1-94CF-B5C4CF447BA0Q34987236-5615D0D7-4B69-4DA6-A960-5F5C6FF2D93BQ35102145-D518C9E7-36C7-47E6-9950-4A0748411904Q35683246-4C4D8015-B122-436B-9472-F8DBACE683DCQ35807563-7742D744-0B83-4410-A476-2B096B107416Q35896019-3F7D2C33-9DEE-4F8C-96BA-AFA2E8427A7FQ35984361-D86BFE28-1130-4DD9-BE05-172AD52EEE0AQ36086314-B59DA99A-2E98-4DE4-B918-B7C93A590CDBQ36300527-2A34CB2D-46CB-432E-A650-C12175546043Q36303117-DD5E3D9A-B051-43DF-A507-BBEFDBCAA84DQ36311358-B8541A8B-0A2A-4EEE-A17D-081EC404B561Q36554534-6D8ABC3D-A1E3-4201-8B65-FA17F10F1451Q36670070-D2EF1C91-6A27-4691-B453-0B2E44C9C74CQ36826569-BE379626-5D70-4CA8-8608-F1B06B112B7CQ36952306-4DCE6D3F-4784-430A-B79B-8E22A2B15953Q37047947-A73698A5-66AA-4952-93E9-8E938D7548F6Q37199815-3E3F5F9B-2335-4F65-B0F2-F3A07B8E47F1Q37225023-65F64936-8522-402D-9FDE-753831A06103Q37300919-930DBB98-9583-4A55-AAAD-AB341B27ED30Q37308847-B5D32067-297F-4721-ABCB-AB3E0CDF1D80Q37595088-1240261A-E829-4441-87BF-D297DB24251DQ37598192-29FF5570-B443-4BF1-A00B-4FE2B6628535Q37615841-BDDC62C3-5F64-4049-9706-0DE7BA37C6A6Q37657283-A0AFDB91-0844-4B3C-A9FD-7CB6EF299975Q37722786-03B0E028-ABE7-4D7D-9E7B-552073C7D3CDQ38094813-CDA22C1D-1EE0-4301-9A62-9C4BEB1BE73FQ38140019-298F14D4-FB07-4A46-83DA-64D45E33ECC7Q38154181-5220D916-7BB1-42AC-AFC9-3D7A33F973A6Q38202135-D885DEAB-DD2D-40ED-B32C-86A6832245BCQ38225962-94251CD2-6D1C-4CE9-B3A8-730444A48700
P2860
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Economic impact of childhood a ...... disorder in the United States.
@en
type
label
Economic impact of childhood a ...... disorder in the United States.
@en
prefLabel
Economic impact of childhood a ...... disorder in the United States.
@en
P2093
P1476
Economic impact of childhood a ...... disorder in the United States.
@en
P2093
Jalpa A Doshi
Jennifer Kahle
Juliana Setyawan
M Haim Erder
Michael J Cangelosi
Paul Hodgkins
Peter J Neumann
Vanja Sikirica
P304
990-1002.e2
P356
10.1016/J.JAAC.2012.07.008
P577
2012-09-05T00:00:00Z